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 ABSTRACT 
 The effects of monensin on transition cow metabolism 
may be dependent on modulation of feeding behavior, 
rumen pH, and expression of key metabolic genes. 
Multiparous Holstein cows were used to determine the 
effects of monensin (400 mg/cow daily) on these vari-
ables. Cows were randomly assigned, based on calving 
date, to control or monensin treatments (n = 16 per 
treatment) 21 d before their expected calving date, and 
cows remained on treatments through 21 d postpartum. 
Feeding behavior and water intake data were collected 
daily. Liver biopsies were conducted after assessing 
BCS and BW on d −21, −7, 1, 7, and 21 relative to 
calving for analysis of triglyceride (TG) content as well 
as mRNA abundance of cytosolic phosphoenolpyruvate 
carboxykinase, carnitine palmitoyltransferase 1a, and 
apolipoprotein B. Blood samples were collected 21, 7, 
and 4 d before expected calving and 1 (day of calving), 
4, 7, 14, and 21 d postpartum for nonesterified fatty 
acid, β-hydroxybutyrate, glucose, insulin, and hapto-
globin analyses. Ruminal pH was collected every 5 min 
on d 1 through 6 postpartum via a wireless indwelling 
probe. On d 7 postpartum, a caffeine clearance test was 
performed to assess liver function. Data were analyzed 
using mixed models with repeated measures over time. 
Monensin decreased mean plasma β-hydroxybutyrate 
(734 vs. 616 ± 41 μM) and peak concentrations (1,076 
vs. 777 ± 70 μM on d 4 postpartum). Monensin also 
decreased time between meals prepartum (143 vs. 126 
± 5.0 min) and postpartum (88.8 vs. 81.4 ± 2.9 min), 
which was likely related to a smaller ruminal pH stan-
dard deviation in the first day after cows changed to 
a lactation ration (0.31 vs. 0.26 ± 0.015). Monensin 
also increased liver mRNA abundance of carnitine 
 palmitoyltransferase 1a (0.10 vs. 0.15 ± 0.002 arbitrary 
units), which corresponded to a slower rate of liver TG 
accumulation from d −7 to +7 (412 vs. 128 ± 83 mg of 
TG/g of protein over this time period). No significant 
effects of monensin supplementation were observed on 
milk production, liver cytosolic phosphoenolpyruvate 
carboxykinase, apolipoprotein B, plasma nonesterified 
fatty acid, glucose, insulin, or haptoglobin. No effects 
on disease incidence were detected, but sample size was 
small for detecting such effects. Overall, results confirm 
that the effects of monensin on transition cows extend 
beyond altered propionate flux. 
 Key words:   monensin ,  transition cow ,  liver function , 
 rumen pH 
INTRODUCTION
 The weeks surrounding parturition are a critical time 
in the life cycle of a high-producing dairy cow. During 
this period, cows make many metabolic adjustments 
to support the transition from pregnancy to lactation. 
Furthermore, dairy cows produce milk in excess of 
their ability to consume energy, resulting in a period of 
negative energy balance in early lactation (Grummer, 
1995). In recent years, monensin has been used to help 
mitigate the effects of negative energy balance, presum-
ably by promoting ruminal production of glucogenic 
precursors (Duffield et al., 2008a,c). 
 Under normal physiological conditions, monensin 
alters ruminal digestion in a manner that augments 
propionate production rate and concentration in the 
rumen (Van Maanen et al., 1978). Greater propionate 
supply leads to increased hepatic gluconeogenesis (Ai-
ello and Armentano, 1987), which could improve the 
overall energetic balance of the transition cow. Thus, 
an increased supply of glucose is often assumed to be 
the primary benefit of monensin supplementation. Ob-
servations of Sauer et al. (1989) support the hypothesis 
that monensin decreases the acetate:propionate ratio 
in transition cows. In contrast, when propionate kinet-
ics were measured during the periparturient period, 
monensin did not affect ruminal propionate production 
(Markantonatos et al., 2009). Some studies have ob-
 Effects of monensin on metabolic parameters, feeding 
behavior, and productivity of transition dairy cows 
C. R.  Mullins ,*  L. K.  Mamedova ,*  M. J.  Brouk ,*  C. E.  Moore ,†  H. B.  Green ,†  K. L.  Perfield ,†  J. F.  Smith ,*  
J. P.  Harner ,‡ and  B. J.  Bradford *1
 * Department of Animal Sciences and Industry and  
 ‡ Department of Biological and Agricultural Engineering, Kansas State University, Manhattan 66506 
 † Elanco Animal Health, Greenfield, IN 46140 
  
 Received July 19, 2011.
 Accepted October 26, 2011.
  1 Corresponding author:  bbradfor@ksu.edu 
Open access under CC BY-NC-ND license.
1324 MULLINS ET AL.
Journal of Dairy Science Vol. 95 No. 3, 2012
served monensin to have beneficial effects on plasma 
lipids or ketones with no effect on plasma glucose 
concentration (Sauer et al., 1989; Petersson-Wolfe et 
al., 2007); in fact, one group even reported a tendency 
for decreased glucose concentration (Stephenson et al., 
1997). This evidence suggests that the beneficial effects 
of monensin likely extend beyond gluconeogenic flux, 
and may even be independent of changes in gluconeo-
genesis.
Transition cow health is directly linked to DMI, partly 
because negative energy balance is not as severe in early 
lactation cows with higher intakes (Bertics et al., 1992). 
Recent transition cow research indicates a beneficial 
effect of monensin on the postpartum DMI curve (Shah 
et al., 2008) or overall DMI (Schroeder et al., 2009), 
but feeding behavior was not measured in either study. 
Research from feedlot cattle suggests dietary monensin 
could modulate intake patterns, thus decreasing dra-
matic changes in rumen pH while cattle are adapting to 
a high-energy diet (Stock et al., 1995; Nagaraja et al., 
1997). Furthermore, data obtained from midlactation 
cows subjected to SARA indicates that administering 
monensin in feed increases meal frequency during the 
challenge and recovery periods (Lunn et al., 2005). The 
hypothesis that monensin affects transition cow rumen 
pH has not been extensively investigated. Monensin 
administered through a controlled-release capsule in-
creased transition cow rumen pH (Green et al., 1999), 
but these data must be interpreted with caution be-
cause ruminal samples were collected using an esopha-
geal tube. Research conducted using indwelling probes 
to measure pH showed no difference between monensin 
supplemented cows and control cows (Mutsvangwa et 
al., 2002; Fairfield et al., 2007), but Mutsvangwa et al. 
(2002) only had 3 animals per treatment and Fairfield 
et al. (2007) used a controlled-release capsule, which 
may not modulate intake as much as dietary monensin. 
Furthermore, neither of these studies examined differ-
ences in variance of rumen pH.
The primary objectives of this study were to deter-
mine the effects of monensin on transition cow feeding 
behavior and metabolic parameters. The secondary 
objectives were to assess the effects of monensin on 
ruminal pH and productivity of transition cows.
MATERIALS AND METHODS
All experimental procedures were approved by the 
Institutional Animal Care and Use Committee at Kan-
sas State University.
Design and Treatments
Thirty-two multiparous Holstein transition cows 
from the Kansas State University Dairy Cattle Teach-
ing and Research Facility (Manhattan) were used in a 
randomized complete block design. Cows were blocked 
by expected calving date (16 blocks) and randomly as-
signed within block to 1 of 2 treatments (n = 16 cows 
per treatment) 21 d before their expected calving date. 
Cows remained on their respective treatments through 
21 d postpartum. The treatment group received monen-
sin (Rumensin; Elanco Animal Health, Greenfield, IN) 
as a top-dress at a rate of 400 mg/cow per day, and the 
control group received no monensin for the duration 
of the study. Cows were dried off an estimated 45 d 
before calving. Monensin was excluded from the far-off 
dry cow ration to help ensure that no cows entering 
the study were influenced by prior monensin exposure. 
Cows entered the study from January to June 2010.
Monensin was premixed into a ground corn carrier 
and 0.91 kg of the premix was offered daily to each 
cow in the treatment group. Monensin treatments were 
administered by top dressing and manually mixing the 
premix into the upper 33% of each TMR once per day. 
The ground corn carrier was top dressed to the control 
cows at the same rate in the same manner. The mo-
nensin dose was selected based on previous research 
(Schroeder et al., 2009) and approached the maximum 
FDA-approved label dose for dry cows of 410 mg/cow 
per day. Diets were formulated to meet or exceed NRC 
(2001) requirements (Table 1). Samples of all dietary 
ingredients were collected weekly and stored at −20°C. 
Upon study completion, feed ingredients were compos-
ited into bimonthly samples for wet chemistry analysis 
of CP, ADF, NDF, ether extract, and ash by Dairy One 
Forage Laboratory (Ithaca, NY).
Management of Cows and Data Collection
Cows were dried off and moved into a freestall pen 
approximately 45 d prepartum where cows received a 
low-energy diet (≈1.35 Mcal/kg) containing no mo-
nensin. Dry cows were moved into the maternity barn 
approximately 1 wk before starting the study. Cows 
were allowed ad libitum access to the designated treat-
ment rations by an electronic gating system (Roughage 
Intake System; Insentec B.V., Marknesse, the Neth-
erlands), 1 cow assigned per gate. After parturition, 
cows were moved into a tie-stall facility where they 
remained through 21 d postpartum. Individual feed 
bunks in the tie-stall facility were suspended from load 
cells and bunk weight was monitored continuously by 
computer. Feed weights and times were stored before 
and immediately after any deviation in bunk weight. 
Dry cows were fed twice daily (0800 and 1530 h) to 
accommodate the capacity of the feeding system used 
prepartum, and lactating cows were fed once daily 
(1500 h) to minimize the time during which feeding 
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behavior could not be recorded. All feeding activity, 
including meal length and size, were recorded electroni-
cally. As-fed feed intake of each cow was recorded on 
a daily basis. As-fed ration consumption was adjusted 
for DM content for determination of meal and daily 
DMI. Dry matter percentage was determined weekly 
for the corn silage and bimonthly for each concentrate 
ingredient; these values were used to determine ration 
DM for each week. Water was offered ad libitum, and 
individual water consumption was also recorded daily 
throughout the study. During summer months, the ma-
ternity barn and tie-stall facility were both cooled using 
evaporative pads.
Cows were milked 3 times daily in a milking parlor, 
and milk yields were recorded at each milking. Milk 
samples were collected from each milking beginning 
at 4 DIM and continuing through 21 DIM. Samples 
were analyzed for concentrations of fat, true protein, 
lactose (B-2000 Infrared Analyzer; Bentley Instruments 
Inc., Chaska, MN), urea nitrogen (MUN spectropho-
tometer; Bentley Instruments Inc.), and somatic cells 
(SCC 500, Bentley Instruments Inc.; Heart of America 
DHIA, Manhattan, KS). Data from individual milkings 
were averaged by cow-day, using a statistical model 
to account for the random effect of milking. Energy-
corrected milk yield was calculated as: 0.327 × milk 
yield + 12.86 × fat yield + 7.65 × protein yield (Dairy 
Records Management Systems, 2010). Solids-corrected 
milk production was calculated as: 12.3 × fat yield + 
6.56 × SNF yield – 0.0752 × milk yield (Tyrrell and 
Reid, 1965).
Body weight was measured 2 h before feeding on d 
−21 and −7 relative to expected calving, and on d 1, 
7, and 21 postpartum. Immediately after BW was ob-
tained, liver samples were collected via needle biopsy. 
For collection of liver tissue, an area spanning the tenth 
and eleventh ribs was shaved, aseptically prepared, and 
anesthetized with 3.5 mL of subcutaneous lidocaine hy-
drochloride (Agri Laboratories Ltd., St. Joseph, MO). 
After 5 min, a #10 blade (Feather Safety Razor Co. 
Ltd., Kita-Ku, Osaka, Japan) was used to make a stab 
incision into the body wall. A 14-gauge × 15 cm biopsy 
needle (SABD-1415–15-T; US Biopsy, Franklin, IN) 
was inserted through the incision and 200 mg of tissue 
was collected (a total of 10 biopsies). Liver samples 
were snap frozen in liquid nitrogen immediately after 
collection, and then stored at −80°C until subsequent 
analysis. Blood samples were collected from the coccy-
geal vessels after each biopsy and also 2 h before feed-
ing on d −4 relative to expected calving date and on d 
4 and 14 postpartum. Approximately 14 mL of blood 
was collected into 2 tubes, one containing potassium 
EDTA and the other containing potassium oxalate with 
sodium fluoride as a glycolytic inhibitor (Vacutainer; 
Becton, Dickinson and Co., Franklin Lakes, NJ). Blood 
samples were centrifuged at 2,000 × g for 10 min im-
mediately after sample collection, and plasma was col-
lected and frozen at −20°C until subsequent analysis 
of glucose, NEFA, BHBA, insulin, and haptoglobin 
concentrations. Body condition score was evaluated by 
3 trained investigators on the same day (±1 d) as BW 
and liver sample collections.
Indwelling ruminal pH probes (Rumen Sensors; 
Kahne Ltd., Auckland, New Zealand) were delivered 
to the rumen as an oral bolus after liver biopsy on d 1 
postpartum. These probes measured rumen pH every 5 
min and used a radio frequency to transmit this data 
to a computer. Electronic data were collected in real 
time and were also stored on the probe. Stored data 
were downloaded during the biopsy on d 7 to ensure 
collection of all recorded data. Measurement of rumen 
pH was limited to the first 7 DIM because of concern 
about drift in pH measurements from probes remaining 
in situ for more than 7 d. Probes removed from 2 cows 
(cannulated for previous studies) on d 7 postpartum 
generated pH values of 6.94 and 6.96 in pH 7.0 buffer 
Table 1. Ingredient and nutrient composition of diets 
Diet composition Prepartum Postpartum
Ingredient (% of DM)
 Corn silage 30.3 34.0
 WCGF1 19.6 21.5
 Prairie hay 39.7 —
 Alfalfa hay — 16.6
 Cottonseed — 6.7
 Corn grain2 6.5 12.4
 Soybean meal 48 4.1 —
 Expeller soybean meal — 7.1
 Micronutrient premix3,4 0.3 2.8
Nutrient (% of DM)
 DM (% as-fed) 57.2 54.2
 CP 13.1 17.3
 ADF 28.4 19.7
 NDF 49.9 36.0
 NFC 35.5 38.0
 Ether extract 3.4 5.0
 Ash 6.9 8.8
 NEL
5 (Mcal/kg) 1.58 1.68
1Wet corn gluten feed (Sweet Bran; Cargill Inc., Blair, NE).
2A portion of the corn grain (0.91 kg/cow daily) served as the top-
dress carrier for 400 mg of monensin (Rumensin; Elanco Animal 
Health, Greenfield, IN) for supplemented cows. The same amount of 
corn alone was top-dressed for control cows.
3Prepartum premix consisted of 42.6% vitamin E premix, 11.9% Se 
premix, 11.6% trace mineral salt, 10.8% limestone, 9.71% vitamin A 
premix, 6.47% 4-plex, 4.31% vitamin D premix, 2.17% magnesium 
oxide, and 0.53% ethylenediamine dihydroiodide.
4Postpartum premix consisted of 48.4% limestone, 27.3% sodium bi-
carbonate, 12.6% trace mineral salt, 6.04% magnesium oxide, 2.33% 
4-plex, 1.51% Se premix, 1.16% vitamin E premix, 0.46% vitamin A 
premix, 0.21% vitamin D premix, and 0.03% ethylenediamine dihy-
droiodide.
5Estimated according to NRC (2001).
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and 4.01 and 3.97 in pH 4.0 buffer, suggesting that data 
analyzed here were valid.
Liver function was assessed using an in vivo caffeine 
metabolism test on d 7 postpartum (Lakritz et al., 
2006). To conduct this test, jugular catheters (#1411; 
Mila International, Erlanger, KY) were inserted and 
caffeine was administered as caffeine-sodium benzoate 
(C4144; Sigma-Aldrich Co., St. Louis, MO) in a sterile 
pyrogen-free normal saline solution (25 mg of caffeine/
mL of solution). Caffeine was infused intravenously in 
a bolus dose at the rate of 1 mg of caffeine/kg of BW, 
and the d 7 postpartum BW was used to calculate the 
amount of caffeine to infuse. Caffeine infusions were 
initiated at feeding time. Blood samples were collected 
immediately before infusion and at 30-min intervals 
for 180 min following infusion using disposable 5-mL 
syringes. Blood was immediately transferred to a tube 
containing potassium EDTA (Vacutainer; Becton, 
Dickinson and Co.). Plasma was collected as described 
above and frozen at −20°C until analysis. Catheter pa-
tency was maintained by flushing with 6 mL of sterile 
3.5% sodium citrate solution following each collection.
Facilities and equipment were observed daily for 
abnormalities. Postpartum cows (and prepartum cows 
with abnormalities) underwent a health inspection 
daily, including monitoring for urine ketones (ReliOn 
ketone test strips; Bayer Healthcare LLC., Mishawaka, 
IN) and rectal temperature. Health records were kept 
throughout the study to register the incidence of ketosis, 
left displaced abomasum, retained placenta, metritis, 
milk fever, lameness, and other abnormalities. Ketosis 
was defined as a urine ketone concentration >80 mg/
dL, or urine ketone concentrations >40 mg/dL for 2 or 
more consecutive days. Mastitis was defined as an SCC 
greater than 200,000 at any milking after d 3 (Dohoo 
et al., 2011). Other diseases were diagnosed according 
to definitions established by Kelton et al. (1998). If 
cows displayed signs of any disorder described they 
were treated according to on-site standard operating 
procedures. Cows were removed from the study if they 
were diagnosed with a displaced abomasum (n = 3) 
or severe lameness (n = 1). Data obtained from these 
cows before removal from the study were included in all 
analyses. Cows diagnosed with a displaced abomasum 
were removed on d 7 (control), 8 (monensin), and 13 
(control) postpartum, respectively. The cow removed 
for lameness issues was removed on d 7 (control) post-
partum.
Liver and Plasma Analyses
Approximately 20 mg of liver was placed in 500 μL 
of chilled phosphate-buffered saline (pH 7.4) and ho-
mogenized. The homogenate was centrifuged at 2,000 
× g for 10 min at 4°C and 100 μL of the supernatant 
was then removed for free glycerol and total protein 
analysis. Triglyceride (TG) content was measured us-
ing a method adapted from Starke et al. (2010). The 
remaining liver homogenate was incubated with 100 μL 
of lipase (porcine pancreatic lipase, MP Biomedicals 
LLC, Solon, OH) for 16 h at 37°C, and glycerol content 
was then determined by an enzymatic glycerol phos-
phate oxidase method (#F6428; Sigma-Aldrich Co.). 
Triglyceride content was calculated based on the differ-
ence between glycerol concentrations before and after 
lipase digestion. Total protein content of the original 
homogenate was analyzed by a Coomassie blue (Brad-
ford, 1976) colorimetric method (kit #23236; Thermo 
Scientific, Pierce, Rockford, IL). To avoid potential bias 
introduced by differences in moisture content of liver 
samples, liver TG concentration was normalized by 
protein concentration, which is unaltered in fatty liver 
(Fronk et al., 1980).
The mRNA abundance of cytosolic phosphoenolpyr-
uvate carboxykinase (cPEPCK), carnitine palmitoyl-
transferase 1a (CPT1a), apolipoprotein B (Apo B), 
and ribosomal protein subunit 9 (RPS9) in liver tissue 
was determined by real-time PCR. Total RNA was iso-
lated from liver samples using a commercial kit (RNeasy 
Lipid Tissue Mini Kit; Qiagen Inc., Valencia, CA) and 
spectroscopy was used to quantify RNA (NanoDrop 
1000; NanoDrop Technologies Inc., Wilmington, DE). 
Coding DNA was then synthesized from 2 μg of total 
RNA using a commercial kit (High-Capacity cDNA 
Reverse Transcription kit; Applied Biosystems, Foster 
City, CA). Quantitative real-time PCR was performed 
in triplicate with one-twentieth of the cDNA product 
in the presence of 200 nM gene-specific forward and 
reverse primers (Table 2) using SYBR green fluorescent 
detection (ABI 7500 Fast; Applied Biosystems). Mes-
senger RNA abundance was quantified using the delta 
delta cycle threshold (Ct) method, with RPS9 used to 
normalize values. Abundance of RPS9 mRNA within 
liver tissue did not differ in response to treatment or 
across days in the study (all P > 0.50), making it a 
valid reference gene.
Plasma was analyzed for NEFA using an enzymatic 
colorimetric procedure (NEFA-HR; Wako Chemicals 
USA Inc., Richmond, VA), glucose by a colorimetric kit 
(kit #439–90901; Wako Chemicals USA Inc.), insulin 
by a bovine-specific sandwich ELISA (#10–1201–01; 
Mercodia AB, Uppsala, Sweden), haptoglobin by a 
bovine-specific ELISA (kit #2410–7 using 3,000-fold 
dilution; Life Diagnostics Inc., West Chester, PA), and 
BHBA using an enzymatic reaction (kit #H7587–58; 
Pointe Scientific Inc., Canton, MI). Absorbance was 
read on a spectrophotometer (PowerWave XS; BioTek 
Instruments Inc., Winooski, VT) and calculations were 
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performed using Gen5 software (BioTek Instruments 
Inc.).
High-performance liquid chromatography was used 
to quantify plasma caffeine following the procedures 
of Lakritz et al. (2006). Briefly, 500 μL of plasma 
was mixed with 500 μL of 0.8 M perchloric acid. The 
mixture was centrifuged at 14,000 × g for 20 min at 
21°C, and 400 μL of the clarified supernatant was 
transferred to an autosampler vial containing 20 μL of 
4 M NaOH. Vials were capped and 50 μL was injected 
into a Discovery BIO Wide Pore C18 guard column (2 
cm × 4 mm, 5-μm particle size; Supelco #568272-U; 
Sigma-Aldrich Co.) and a Discovery BIO Wide Pore 
C18 column (25 cm × 4.6 mm, 5-μm particle size; Su-
pelco #568222-U, Sigma-Aldrich). The photochemical 
reaction was carried out in a mobile phase consisting 
of 20 mM phosphate buffer (pH 3.0)-acetonitrile, 85:15 
(vol/vol), at a flow rate of 1 mL/min. Absorbance was 
read at 273 nm using an Acutect 500 UV/Vis detector 
(#06–653–5; Thermo Fisher Scientific, Waltham, MA).
Data and Statistical Analysis
Feeding behavior variables were calculated from 
logged data that included the start and end weights as 
well as start and end times of meals. To generate mean-
ingful meal pattern data, feeding bouts are grouped into 
meals, but no broadly accepted definition exists of what 
constitutes a meal. Previous reports have used mini-
mum thresholds for intermeal intervals ranging from 2 
to more than 40 min (Tolkamp et al., 2000). Selecting 
a threshold was complicated in this study because cows 
started in a pen setting and then moved into tie-stalls. 
Therefore, approaches to data analysis were examined 
from 4 studies conducted by different laboratories. In 
these studies, minimum intermeal intervals were de-
fined as 7.5 (Dado and Allen, 1993), 8 (Heinrichs and 
Conrad, 1987), 20 (Vasilatos and Wangsness, 1980), 
and 27.74 min (DeVries et al., 2003). For our feeding 
systems and housing situations, a 12-min intermeal 
interval was determined to be appropriate, because it 
is within the range of previously used thresholds and 
because it generated meal frequencies similar to those 
reported in the studies above. Therefore, meals were 
combined if the intermeal interval was less than 12 min. 
After combining meals accordingly, any meal <0.2 kg of 
DM was excluded from behavior analysis. Ruminal pH 
data were analyzed to determine mean pH, standard 
deviation, amount of time spent below pH 5.8, and area 
(pH × min) under pH 5.8 for each cow each day. The 
threshold of 5.8 is representative of SARA according to 
previously established standards (Dohme et al., 2008). 
Caffeine elimination half-lives were determined by plot-
ting post-infusion caffeine concentrations over time for 
each animal, performing an exponential regression on 
these values (y = a × e−bx, where a = intercept and 
b = slope), and using the equation half-life = ln 2/
slope (Lakritz et al., 2006). The distribution volume 
was determined as the dose of caffeine infused divided 
by the intercept.
Differences in caffeine elimination were determined 
using the REML procedure of JMP (version 8.0; SAS 
Institute Inc., Cary, NC) with the fixed effect of treat-
ment and the random effect of cow. Other data were 
analyzed using mixed models with repeated measures 
over time (SAS 9.1; SAS Institute Inc.). Spatial power 
covariance structures were used to model repeated mea-
sures over time within cow for data with time points 
that were not equally spaced (BW, BCS, and plasma 
and liver variables). For data collected daily (DMI, pH, 
feeding behavior, and production variables), autore-
gressive [AR(1)] covariance structures were used. Fixed 
effects were treatment, day relative to parturition, and 
treatment × day. Individual cows were treated as a ran-
dom effect. Values were deemed outliers and omitted 
from analysis when studentized residuals were >|3.0|. 








CPT1a DV820520.1 CTTCCCATTCCGCACTTTC 616–719
CCATGTCCTTGTAATGAGCCA
cPEPCK NM_174737.2 CGAGAGCAAAGAGATACGGTGC 427–562
TGACATACATGGTGCGACCCT
Apo B XM_583270.3 TCCTTGATTCCACATGCAGCT 8,610–8,720
GGTGTGCAAAGGATGCGTTAG
RPS9 DT860044.1 GAACAAACGTGAGGTCTGGAGG 233–344
ATTACCTTCGAACAGACGCCG
1CPT1a = carnitine palmitoyl transferase 1a; cPEPCK = cytosolic phosphoenolpyruvate carboxykinase; Apo 
B = apolipoprotein B; RPS9 = ribosomal protein subunit 9.
2From NCBI Entrez Nucleotide Database (http://www.ncbi.nlm.nih.gov/sites/entrez?db=nucleotide).
3Amplicons span an exon-exon boundary, as predicted by aligning the specified sequence to the bovine genome 
using Splign (http://www.ncbi.nlm.nih.gov/sutils/splign).
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After initial outlier removal, the model was repeated 
and studentized residuals >|3.5| were deemed outliers. 
No more than 3% of data were removed from any single 
analysis. Plasma haptoglobin, insulin, liver TG, and 
CPT1a and Apo B mRNA data were log-transformed 
before analysis to achieve normal residual distributions, 
and the reported means and standard errors were back-
transformed (Bland and Altman, 1996). Milk SCC data 
were transformed to somatic cell linear score (Schukken 
et al., 2003). Prepartum and postpartum measures were 
analyzed separately for DMI, water intake, and feeding 
behavior. Effects were declared significant at P < 0.05, 
and trends are discussed at P < 0.10.
RESULTS AND DISCUSSION
No significant difference occurred between treatments 
in deviation from expected calving date (−2.0 vs. −0.8 
± 1.0 d for the control and monensin, respectively; P 
= 0.40). Actual calving dates ranged from 10 d before 
expected calving to 7 d after expected calving.
Feed Intake, Rumen pH, BW,  
Body Condition, and Milk Production
Daily DMI is shown in Figure 1A. Intake of DM 
decreased before parturition and increased after par-
turition in both groups (P < 0.001), which resembles 
intake patterns observed in many transition cow studies 
(Ingvartsen and Andersen, 2000). Dry matter intake 
was not affected by treatment pre- or postpartum. This 
was surprising because other transition cow research 
has shown monensin to have an effect. Sauer et al. 
(1989) reported 1.2 kg/d lower DMI of cows fed 30 g of 
monensin/ton of DM compared with cows receiving no 
monensin from 1 wk prepartum through 3 wk postpar-
tum. Shah et al. (2008) observed a linear decrease in 
DMI over a complete lactation when monensin was fed 
at 0, 7, 15, or 22 g/ton of DM. The reports of Sauer et 
al. (1989) and Shah et al. (2008) align with the 2.3% 
decrease in DMI concluded by meta-analysis using data 
from 4,445 dairy cows in all stages of lactation (Duff-
ield et al., 2008b). In contrast, researchers found that 
monensin accelerated the rate of DMI increase in early 
lactation (Shah et al., 2008) and increased postpartum 
DMI in monensin-supplemented cows (Schroeder et al., 
2009), although treatment means were not reported in 
these abstracts.
Although intakes were similar, monensin supplemen-
tation tended to decrease time between meals (Table 
3 and Figure 1B; P < 0.08), which is consistent with 
reports showing that inclusion of monensin in feedlot 
diets results in more consistent feed intake patterns 
throughout the day (Burrin et al., 1988; Erickson et al., 
2003). Even though the intermeal interval was smaller 
with monensin supplementation, the number of meals 
consumed per day and average meal duration did not 
Figure 1. Dry matter intake (A), intermeal interval (B), and meal 
size (C) during the experimental period. A. An effect of day pre- and 
postpartum was observed (P < 0.001); prepartum standard error of 
the means = 0.88, postpartum standard error of the means = 0.87. 
B. Monensin shortened intermeal interval prepartum (P < 0.03) and 
tended to shorten intermeal interval postpartum (P < 0.08). An effect 
of day postpartum was observed (P < 0.001); prepartum standard 
error of the means = 10.6, postpartum standard error of the means 
= 4.77 († denotes P < 0.10; * denotes P < 0.05). C. An effect of day 
pre- and postpartum on meal size was observed (P < 0.001), and a 
treatment × day interaction was detected postpartum (P < 0.02); 
prepartum standard error of the means = 0.18, postpartum standard 
error of the means = 0.09.
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differ between treatments. Although meal sizes were 
similar overall (Table 3), a treatment × day interaction 
was observed for postpartum meal size (effects on d 8, 
15, 20, and 21; Figure 1C). The small increase in meal 
frequency, coupled with similar to larger meal sizes, 
resulted in small, nonsignificant increases in DMI for 
monensin-supplemented cows during the postpartum 
period. Lunn et al. (2005) observed similar meal pat-
tern results during a SARA challenge with midlacta-
tion cows, and concluded that monensin affects feeding 
behavior during times when rumen pH is low. In their 
study, mean ruminal pH was greater than the 5.9 ob-
served in our study (Lunn et al., 2005). This implies 
that the cows in our study were experiencing SARA to 
a greater degree, and that decreased intermeal interval 
in fresh cows on monensin treatment may have been re-
lated to the low ruminal pH observed. However, monen-
sin’s effects in the current study were not dependent on 
the presence of SARA. Cows received a low-energy diet 
prepartum that should not have caused SARA, yet we 
still observed a shorter intermeal interval prepartum, 
suggesting that another mechanism must be involved 
in this response to monensin.
As expected, DMI was noticeably different pre- and 
postpartum; however, the dramatic decrease in meal 
length (Table 3) for postpartum cows compared with 
prepartum cows likely reflects differences in feeding 
behavior of cows in tie-stall versus pen housing rather 
than a true stage of production effect. DeVries et al. 
(2003) indirectly examined this hypothesis and found 
that cows housed in a freestall barn consumed dramati-
cally fewer and larger meals than cows housed in tie-
stall facilities (Vasilatos and Wangsness, 1980; Dado 
and Allen, 1995). These 3 studies all investigated early 
lactation cows, and it was suggested that social interac-
tions result in less frequent access to feed in a freestall 
situation, and that when cows gain access to the feed 
bunk, they remain there even when not eating (DeVries 
et al., 2003).
Daily water consumption did not differ between 
treatments throughout the experimental period (Table 
3). Water intake of both groups was steady throughout 
the 21-d prepartum period. Postpartum water intake 
started around 80 L/d and, as expected, increased (P 
< 0.001) to approximately 115 L/d by d 21.
Mean ruminal pH and the total time per day that 
ruminal pH was below 5.8 were not affected by treat-
ment or day (P > 0.28; Table 4) during the first 6 d 
postpartum. Some researchers suggest that a key role of 
monensin is to alter ruminal pH, but that lactate needs 
to exceed approximately 5 mM for monensin to have 
such an effect (Osborne et al., 2004). Thus, fresh cow 
diets likely do not contain enough rapidly fermentable 
carbohydrates to promote excessive levels of lactic acid. 
If this is true, it would explain why monensin typically 
increases pH in feedlot studies (Nagaraja et al., 1981; 
Burrin and Britton, 1986) but few effects have been 
observed in dairy cattle. The lack of an effect on mean 
ruminal pH and time below 5.8 coincides with results 
from both transition (Mutsvangwa et al., 2002; Fair-
field et al., 2007) and midlactation cow studies (Ruiz 
et al., 2001; Osborne et al., 2004; Mathew et al., 2011); 
however, these studies did not examine differences in 
variance of ruminal pH. In our study, cows supplement-
ed with monensin had a smaller standard deviation of 
ruminal pH (Figure 2; P < 0.02) on d 1 postpartum, 
but no differences were detected beyond d 1. The more 
stable ruminal pH in monensin-supplemented cows 
could have facilitated quicker adaptation of ruminal 
microflora to the lactation diet, and may be related to 
the shorter intermeal interval in this group. Notably, 
an effect of day was detected for area under pH 5.8 (P 
< 0.03), with a relatively steady increase from 113 min 
× pH units on d 1 to 169 ± 18 min × pH units on d 6 
postpartum (data not shown).
Cows receiving monensin tended to have a lower BW 
on d 1 postpartum (P < 0.09), but no other differences 
were observed between treatments for BCS or BW 
Table 3. Feed and water intake and feeding behavior during the experimental period 
Item Control Monensin SEM P-value
Prepartum water intake (L/d) 20.6 19.1 1.6 0.48
Prepartum DMI (kg/d) 13.9 14.1 0.6 0.83
 Intermeal interval (min) 143 126 5.0 0.03
 Meal frequency (d−1) 7.57 8.05 0.36 0.35
 Meal size (kg of DM) 1.85 1.85 0.12 0.99
 Meal length (min) 43.4 42.9 2.3 0.88
Postpartum water intake (L/d) 101.6 101.6 2.7 0.99
Postpartum DMI (kg/d) 18.4 19.8 0.6 0.14
 Intermeal interval (min) 88.8 81.4 2.9 0.08
 Meal frequency (d−1) 13.7 14.8 0.5 0.12
 Meal size (kg of DM) 1.38 1.47 0.06 0.29*
 Meal length (min) 14.1 14.5 0.6 0.65
*Treatment × day interaction detected (P < 0.02).
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(data not shown). On average, cows lost 0.6 BCS units 
(3.3 to 2.7) and 110 kg of BW (767 to 657 kg) during 
the experiment. Milk production (39.0 vs. 39.3 ± 1.7 
kg/d for control and monensin, respectively; P = 0.92) 
and concentrations of fat, protein, lactose, and SNF 
did not differ (P > 0.18) between dietary treatments, 
but MUN was higher for monensin-supplemented cows 
(11.8 vs. 10.4 ± 0.42 mg/dL; P < 0.02). No clear ex-
planation exists for the observed effect on MUN. It 
has been shown that impaired liver function associated 
with lipid accumulation results in decreased ureagenic 
capability (Strang et al., 1998), but neither liver TG 
content nor the caffeine clearance test demonstrated 
dramatic effects of monensin on liver health. The MUN 
response could also be a result of monensin’s ruminal 
protein sparing effect, allowing more escape protein 
to reach the small intestine. Duffield et al. (1998) ob-
served a rise in blood urea nitrogen in early postpartum 
cows given monensin controlled-release capsules and 
suggested that it could be related to gluconeogenesis 
from nonessential AA, because the prerequisite deami-
nation results in increased urea production. Blood urea 
nitrogen distributes freely into body fluids, including 
milk, so this proposed mechanism could help explain 
why MUN was higher in cows fed monensin. This is 
something of a paradox, however, because if monensin 
increases propionate supply, it may decrease the need 
to use AA for glucose production, potentially limiting 
ureagenesis. A simpler explanation is to consider that 
monensin-supplemented cows consumed, on average, 
an additional 0.23 kg of CP/d, with no increase in 
milk protein yield. If metabolizable protein supply did 
not limit milk protein yield in either group, then the 
increase in MUN for the monensin treatment was an 
expected response to increased CP intake.
Metabolic and Endocrine Changes
Plasma NEFA, BHBA, glucose, and insulin concen-
trations are displayed in Figure 3. As expected, plasma 
NEFA concentrations increased dramatically from 222 
± 80 μM 21 d before expected calving to a peak of 878 
± 80 μM on d 1 postpartum (Figure 3A; P < 0.001). 
Monensin supplementation did not significantly alter 
NEFA concentrations throughout the study. This was 
somewhat unexpected, because a meta-analysis includ-
ing 24 studies with plasma NEFA data demonstrated 
that monensin could decrease NEFA concentration 
(Duffield et al., 2008a). However, the small mean 
response to monensin (36.6 μEq/L) reported in the 
meta-analysis was similar to the numerical difference 
between treatments in this study, suggesting that the 
current study was simply underpowered to detect such 
an effect.
Monensin treatment decreased plasma BHBA over 
the course of the entire study (734 vs. 616 ± 40.9 μM; 
P < 0.05) with a significant effect of day (P < 0.001) 
and a treatment × day interaction (P < 0.01; Figure 
3B). Most notably, monensin significantly decreased 
plasma BHBA on d 4 postpartum (777 vs. 1,077 ± 71 
μM; P < 0.01). The effect on BHBA is not surpris-
Table 4. Rumen pH parameters from d 1 through 7 and results of d 7 caffeine clearance test 
Item Control Monensin SEM P-value
Ruminal pH measures
 Mean pH 5.90 5.89 0.04 0.84
 SD of ruminal pH 0.302 0.298 0.012 0.80*
 Time under pH 5.8 (min/d) 569.3 583.5 62.1 0.87
 Area under pH 5.8 (pH × min/d) 140.1 143.2 20.2 0.91
Caffeine clearance measures
 Half-life (min) 226.3 207.9 13.5 0.34
 Distribution volume (L) 444.0 445.7 15.0 0.94
*Treatment × day interaction detected (P < 0.05).
Figure 2. Standard deviation of rumen pH until d 7 postpartum. 
Monensin decreased the standard deviation of ruminal pH for the first 
day after calving (P < 0.02). Standard error of the means = 0.02 (* 
denotes P < 0.05).
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ing given that almost all relevant publications have 
reported similar decreases in BHBA (Duffield et al., 
2008a). Lower BHBA concentrations are likely a result 
of more complete FA oxidation in the liver. Monensin 
can increase the supply of propionate to the liver (Van 
Maanen et al., 1978), which could redirect acetyl-CoA 
toward oxidation in the TCA cycle and away from ke-
tone production (Allen et al., 2009).
Plasma glucose concentrations decreased after par-
turition in both groups (P < 0.001), but monensin 
did not affect plasma glucose concentrations pre- or 
postpartum. Meta-analysis indicated that monensin 
can increase plasma glucose concentration of transi-
tion cows, but increases were not consistently reported 
(Duffield et al., 2008a). Furthermore, because monen-
sin does not always affect ruminal propionate produc-
tion in transition cows (Markantonatos et al., 2009), we 
would not necessarily expect substrate-driven changes 
in gluconeogenic flux, although monensin could also 
alter gluconeogenic enzyme capacity (Karcher et al., 
2007). Arieli et al. (2001) did not observe changes in 
blood glucose concentration, but observed an increase 
in distribution space and glucose pool size when feed-
ing monensin to prepartum cows, suggesting increased 
uptake of glucose by peripheral tissues in response to 
monensin. If monensin does, in fact, alter clearance 
of plasma glucose, then plasma glucose concentration 
is a poor proxy for gluconeogenic flux and glucose 
turnover data are required to evaluate the effects of 
monensin on this pathway accurately. Data in this 
area are limited, but in one study, rate of appearance 
of glucose was 10% higher for monensin-supplemented 
cows on an equivalent DMI basis (Wheelock et al., 
2009).
Overall, monensin treatment did not affect plasma 
insulin concentration. However, effects of day (P < 
Figure 3. Plasma concentrations of NEFA (A), BHBA (B), glucose (C), and insulin (D) during the experimental period. A. No treatment 
effects were detected, but a day effect was observed (P < 0.001); standard error of the means = 84.9. B. Effects of treatment (P < 0.05), day (P 
< 0.001), and treatment × day interaction (P < 0.01) were detected; standard error of the means = 73.6 (* denotes P < 0.05). C. No treatment 
effects were detected, but a day effect was observed (P < 0.001); standard error of the means = 2.38. D. Significant effects of day (P < 0.001) 
and day × treatment interaction (P < 0.05) were detected. Cows receiving monensin tended to have higher plasma insulin concentrations on d 
7 postpartum. Standard errors of the means are shown on D († denotes P < 0.10).
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0.001) and treatment × day interaction (P < 0.05) were 
significant. The treatment × day interaction showed 
a tendency for higher plasma insulin concentration 
in monensin-fed cows on d 7 postpartum (P < 0.08). 
In the meta-analysis by Duffield et al. (2008a), data 
from 5 relevant reports in which plasma insulin was 
measured did not demonstrate an effect of monensin 
on insulin concentration in transition cows. Increased 
insulin concentration appears unlikely to be a primary 
mechanism by which monensin alters periparturient 
metabolism.
A day effect (P < 0.001) was detected for plasma 
haptoglobin concentration (Figure 4) as a result of an 
increase in the early postpartum period. Haptoglobin 
is an acute phase protein that increases in concen-
tration during times of inflammation (Bionaz et al., 
2007); therefore, we expected the effect of day during 
the transition period. Monensin did not significantly 
alter haptoglobin concentrations. The numerical differ-
ence between treatments on d 1 postpartum, however, 
seemed to correspond with the findings of Crawford et 
al. (2005), who reported elevated haptoglobin in dis-
eased transition heifers given monensin. We attempted 
to assess whether a similar differential response could 
be found in our data, but were unable to conduct a valid 
analysis because only 1 cow on the monensin treatment 
had an observed health disorder before d 4 postpartum.
Liver Indices
Many metabolic fuels are oxidized or synthesized by 
the liver, making the health and function of this organ 
extremely important to early lactation dairy cows. In 
the present study, TG content, mRNA abundance of 
key genes, and caffeine clearance were used as measures 
of the liver’s metabolic function.
Liver TG content throughout the experiment is 
shown in Figure 5A. All cows experienced an increase 
in liver TG following parturition (P < 0.001). A trend 
for a treatment × day interaction was detected (P < 
0.09), driven primarily by a tendency for increased liver 
TG content in monensin-treated cows on d −7 (P < 
0.09) and the numerical difference in the opposite di-
rection observed on d 7 postpartum. Little data exists 
reporting transition cow liver TG content in response 
to monensin, but one group reported a tendency for 
animals administered monensin to have lower liver TG 
content (P = 0.12) and higher glycogen content (P = 
0.02) 3 wk into lactation (Zahra et al., 2006).
A major source of metabolic fuel and substrate for 
liver TG synthesis in transition cows are NEFA. Carni-
tine palmitoyl transferase 1a is important for translo-
cating FA from the cytosol into the mitochondria, mak-
ing it a central component for determining oxidative 
flux of FA within the liver (Drackley, 1999). If a cow 
fed monensin is more efficient at oxidizing FA, less liver 
TG accumulates, which has positive implications for 
transition cow health (Herdt, 1988). Results from this 
study indicated that liver CPT1a mRNA was greater 
in cows fed monensin (0.10 vs. 0.15 ± 0.002 arbitrary 
units, P < 0.04; Figure 5B). The difference was driven 
mainly by effects on d −7 and 1 (both P < 0.05). These 
results suggest a novel mechanism underlying the role 
of monensin in improving the overall health of transi-
tion cows. This response led us to evaluate whether 
treatment altered the rate of liver TG accumulation 
during this time period. A contrast statement was used 
to determine whether the increase in liver TG from 
d −7 to d 7 differed by treatment. The increase in 
liver TG concentration was significantly greater for the 
control compared with monensin (412 vs. 128 ± 83 mg 
of TG/g of protein over this period, P = 0.03). This 
differential rate of TG accumulation coincides with the 
treatment effects on liver CPT1a mRNA abundance. 
Previous findings also have suggested that monensin 
increases the liver’s capacity to export very low density 
lipoprotein (Mohebbi-Fani et al. 2006). This stimulated 
us to measure expression of Apo, B in liver tissue 
from d −7 to 7, but treatment had no effect on Apo 
B mRNA abundance during this period (P = 0.42). 
Expression of Apo B was upregulated over this time 
period (0.18, 0.35, and 1.13 ± 0.28 arbitrary units for 
d −7, 1, and 7, respectively). Expression of Apo B ap-
peared to adapt to the increased TG synthesis in the 
liver of these transition cows, but monensin did not 
regulate lipoprotein secretion through Apo B transcrip-
tion in this experiment.
Figure 4. Plasma concentrations of haptoglobin during the experi-
mental period. No treatment differences were detected; however, an 
effect of day was detected (P < 0.001). Standard errors of the means 
are shown on the graph.
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The evidence that monensin lowers transition cow 
plasma ketone concentrations is substantial (Duffield 
et al., 2008a), but most reports referenced in the meta-
analysis of Duffield et al. (2008a) explain the effect 
on ketones through increased supply of propionate 
for hepatic gluconeogenesis. To our knowledge, our 
report is the first to consider the effects of monensin 
on abundance of CPT1a in dairy cows, and suggests 
that monensin has a positive effect on lipid metabo-
lism in the liver. Although β-oxidation of FA can result 
in either complete oxidation of acetyl-CoA or ketone 
production, increased CPT1a abundance could benefit 
liver function because increased mitochondrial oxida-
tion could 1) limit TG synthesis, 2) decrease reliance on 
peroxisomal oxidation with its subsequent production 
of reactive oxygen species, and 3) prevent accumulation 
of lipid metabolites that may impair metabolic function 
(FA-CoA, ceramides, and peroxides, among others). 
Nevertheless, these findings should not be over-inter-
preted because our results are limited to the transcript 
level, and we did not observe obvious corresponding 
decreases in liver TG content or hepatic inflammation 
(as measured by plasma haptoglobin concentration).
The liver is the primary site for gluconeogenesis, and 
cPEPCK is thought to be a rate-determining enzyme for 
hepatic gluconeogenesis from propionate, lactate, and 
AA (Greenfield et al., 2000). The relative abundance 
of liver cPEPCK mRNA differed across day of study 
(P < 0.02), but was not different between treatments. 
The slight change through the transition period (an 
85% increase from d 1 to 21 postpartum) is consistent 
with previous reports (Greenfield et al., 2000; Hartwell 
et al., 2001); however, when monensin was fed to tran-
sition cows, cPEPCK expression increased (Karcher 
et al., 2007), so it was surprising that no differences 
were detected in this study. Because cPEPCK is one of 
several rate-determining gluconeogenic enzymes, this is 
consistent with the lack of treatment effect on plasma 
glucose concentration, although mRNA abundance is 
not a measure of enzyme activity and plasma glucose 
concentration is not a measure of gluconeogenic flux.
Liver diseases, including fatty liver, decrease activity 
of the cytochrome P450 (CYP450) enzyme complex 
(Frye et al., 2006), and activity of CYP450 can serve as 
an index of normal liver function. We assessed metabo-
lism of caffeine because it is metabolized by CYP450 
and has few side effects when administered at low doses 
(Lakritz et al., 2006). Results of the caffeine challenge 
tests are shown in Table 4. Caffeine elimination half-life 
was 226 and 208 ± 13.5 min for control and monensin 
cows, respectively, and no differences were detected (P 
= 0.34). The volume of distribution of caffeine also was 
calculated, and similar results across treatments sug-
gest no bias in administering the caffeine dose; thus, 
our results do not indicate that CYP450 activity was 
enhanced or impaired by monensin treatment. Reports 
of caffeine clearance in dairy cows are limited. DeGraves 
et al. (1995) examined hepatic function of later-lacta-
tion dairy cows and reported an average elimination 
half-life of 228 min (range was 156 to 414 min), which 
was remarkably similar to our results. In the current 
study, caffeine elimination half-life also was correlated 
with log-transformed plasma haptoglobin concentra-
tion (P = 0.03, r = 0.41), similar to results from a 
separate study conducted in our laboratory (Morey et 
al., 2011). These positive correlations between mark-
ers of impaired liver function and liver inflammation 
are consistent with their utility as gauges of metabolic 
health in transition cows.
Figure 5. Triglyceride (TG) content (A) and mRNA abundance 
of carnitine palmitoyl transferase 1a (CPT1a; B) in liver tissue during 
the experimental period. A. A tendency for a treatment × day effect 
was detected (P < 0.09). Liver TG content increased in both groups 
during the study period (P < 0.001); standard errors of the means are 
shown on the graph († denotes P < 0.10). B. Monensin significantly 
increased abundance of CPT1a relative to the control gene ribosomal 
protein subunit 9 (RPS9; P < 0.04); standard errors of the means are 
shown on the graph (* denotes P < 0.05).
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The incidences of health disorders are shown in Table 
5. No differences were found between treatment groups. 
Because only 32 experimental units were used for this 
study, detecting differences in disease incidence would 
have been difficult. A more powerful assessment of the 
effects of monensin on cow health is the meta-analysis 
conducted by Duffield et al. (2008c). These research-
ers combined data from 16 papers; overall, monensin 
significantly decreased the relative risk of ketosis, dis-
placed abomasum, and mastitis. The BHBA response 
observed in our study is consistent with the means 
reported in the meta-analysis (Duffield et al., 2008c). 
Therefore, monensin likely lowers the risk of diseases 
such as ketosis and displaced abomasa because these 
diseases are related to energy status, although our study 
lacked statistical power to detect these differences.
CONCLUSIONS
In this first report of monensin’s effects on feeding 
behavior combined with ruminal pH dynamics in transi-
tion cows, monensin increased meal frequency and min-
imized ruminal pH variance in the first day after cows 
changed to a lactation ration. Monensin supplementa-
tion also significantly increased liver mRNA abundance 
of CPT1a, a key mediator of liver mitochondrial FA 
oxidation, and decreased the rate of liver TG accumula-
tion in the 2 wk around parturition. Consistent with 
previous results, monensin significantly decreased peak 
plasma BHBA concentrations in postpartum cows, but 
did not alter concentrations of plasma NEFA, glucose, 
or insulin in the postpartum period. Despite the ob-
served beneficial effects on metabolism, no significant 
effects on milk production or disease incidence were 
detected.
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